How would you like to be the guy that shorted the highest gaining stock of the year? You could tell your grandkids someday? "Hey kids, you know Apple, right? Well, grandpa shorted it at 20! Pre-split! How do you like that?!"
If you examine Murphy's very direct statements, they will only issue shares in the future if it is for a specific expansion project and the return justifies it. They don't need money for working capital. And management is not paying themselves a lot of money.
Advaxis also. His modus operandi is to try to establish credibility by admitting the truth--i.e., the extremely promising biotechnology that should garner a premium valuation, and then play the usual scare card: "what's the rush? Wait and see what happens before investing." Translation: please don't buy this stock until my hedgie sponsors cover their large short position and accumulate.
Economies of scale will kick in big time. But all that matters at this stage is revenue and, more importantly, revenue growth. And, we deserve a significant premium, as per your example with PUMA. Not that large, but significant.
He doesn't speak English. He is copying from a script.
Thanks for the analysis. That would explain the lack of (thus far) b&b recovery for Jesi. People are debating a somehwat inapplicable point on that issue, because it depends on how up the spine the complete injury is, of course. A 10-12 dermatome functional (and sensory) improvement is not good; it is remarkable, considering that the chances of it happening to two consecutive patients spontaneously is approximately 400:1. If the third patient has the same response, the odds go up to 8000:1, then 160,000:1, and so on.
Your soft bashing is really not good. Have you considered being a caddy?